We've found
184,457
clinical trials
Alzheimer's Disease Clinical Trial
An Efficacy and Safety Trial of Verubecestat (MK-8931) in Mild to Moderate Alzheimer's Disease (P07738)
Status: Enrolling,
Phase
II, III
Updated: 10/22/2015
Click here to add this to my saved trials
Alzheimer's Disease Clinical Trial
An Efficacy and Safety Trial of Verubecestat (MK-8931) in Mild to Moderate Alzheimer's Disease (P07738)
Status: Enrolling,
Phase
II, III
Updated: 10/22/2015
Click here to add this to my saved trials
Alzheimer's Disease Clinical Trial
An Efficacy and Safety Trial of Verubecestat (MK-8931) in Mild to Moderate Alzheimer's Disease (P07738)
Status: Enrolling,
Phase
II, III
Updated: 10/22/2015
Click here to add this to my saved trials
Alzheimer's Disease Clinical Trial
An Efficacy and Safety Trial of Verubecestat (MK-8931) in Mild to Moderate Alzheimer's Disease (P07738)
Status: Enrolling,
Phase
II, III
Updated: 10/22/2015
Click here to add this to my saved trials
Alzheimer's Disease Clinical Trial
An Efficacy and Safety Trial of Verubecestat (MK-8931) in Mild to Moderate Alzheimer's Disease (P07738)
Status: Enrolling,
Phase
II, III
Updated: 10/22/2015
Click here to add this to my saved trials
Type 2 Diabetes Mellitus Clinical Trial
A Study of the Safety and Efficacy of MK-0431A XR in Pediatric Participants With Type 2 Diabetes Mellitus (MK-0431A-289)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Type 2 Diabetes Mellitus Clinical Trial
A Study of the Safety and Efficacy of MK-0431A XR in Pediatric Participants With Type 2 Diabetes Mellitus (MK-0431A-289)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Neurology, Psychiatry / Psychology Clinical Trial
A Study of Brain Aging in Vietnam War Veterans
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Rheumatoid Arthritis (RA) Clinical Trial
Safety and Efficacy of MK-8457 and Methotrexate (MTX) in Patients With Active Rheumatoid Arthritis Despite MTX Therapy (MK-8457-008 AM6)
Status: Enrolling
Updated: 7/26/2013
Click here to add this to my saved trials
Non-Small Cell Lung Cancer Clinical Trial
A Multinational, Randomized, Open-Label Study of Custirsen In Patients With Advanced or Metastatic (Stage IV) Non-Small Cell Lung Cancer
Status: Enrolling,
Phase
III
Updated: 9/1/2015
Click here to add this to my saved trials
Relapsed or Refractory Systemic Light Chain Amyloidosis Clinical Trial
Study of Dexamethasone Plus IXAZOMIB (MLN9708) or Physicians Choice of Treatment in Relapsed or Refractory Systemic Light Chain (AL) Amyloidosis
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Medullary Thyroid Cancer Clinical Trial
Expanded Access of Cabozantinib in Medullary Thyroid Cancer
Status: Enrolling
Updated: 11/6/2012
Click here to add this to my saved trials
Pediatric Patients Treated With Proton Beam Radiation Therapy Clinical Trial
PPCR: Registry for Pedi Patients Treated With Proton RT
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Pediatric Patients Treated With Proton Beam Radiation Therapy Clinical Trial
PPCR: Registry for Pedi Patients Treated With Proton RT
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Hepatitis C Clinical Trial
An Open-Label Study of the Effect of Telaprevir in Combination With Peginterferon Alfa-2b and Ribavirin in Pediatric Subjects Infected With Hepatitis C Virus
Status: Enrolling,
Phase
I, II
Updated: 8/7/2014
Click here to add this to my saved trials
Hepatitis C Clinical Trial
An Open-Label Study of the Effect of Telaprevir in Combination With Peginterferon Alfa-2b and Ribavirin in Pediatric Subjects Infected With Hepatitis C Virus
Status: Enrolling,
Phase
I, II
Updated: 8/7/2014
Click here to add this to my saved trials
Type 2 Diabetes Mellitus Clinical Trial
A Study to Assess Cardiovascular Outcomes Following Treatment With MK-3102 in Participants With Type 2 Diabetes Mellitus (MK-3102-018)
Status: Enrolling,
Phase
III
Updated: 8/28/2014
Click here to add this to my saved trials
Type 2 Diabetes Mellitus Clinical Trial
A Study to Assess Cardiovascular Outcomes Following Treatment With MK-3102 in Participants With Type 2 Diabetes Mellitus (MK-3102-018)
Status: Enrolling,
Phase
III
Updated: 8/28/2014
Click here to add this to my saved trials
Type 2 Diabetes Mellitus Clinical Trial
A Study to Assess Cardiovascular Outcomes Following Treatment With MK-3102 in Participants With Type 2 Diabetes Mellitus (MK-3102-018)
Status: Enrolling,
Phase
III
Updated: 8/28/2014
Click here to add this to my saved trials
Type 2 Diabetes Mellitus Clinical Trial
A Study to Assess Cardiovascular Outcomes Following Treatment With MK-3102 in Participants With Type 2 Diabetes Mellitus (MK-3102-018)
Status: Enrolling,
Phase
III
Updated: 8/28/2014
Click here to add this to my saved trials
Type 2 Diabetes Mellitus Clinical Trial
A Study to Assess Cardiovascular Outcomes Following Treatment With MK-3102 in Participants With Type 2 Diabetes Mellitus (MK-3102-018)
Status: Enrolling,
Phase
III
Updated: 8/28/2014
Click here to add this to my saved trials
Type 2 Diabetes Mellitus Clinical Trial
A Study to Assess Cardiovascular Outcomes Following Treatment With MK-3102 in Participants With Type 2 Diabetes Mellitus (MK-3102-018)
Status: Enrolling,
Phase
III
Updated: 8/28/2014
Click here to add this to my saved trials
Type 2 Diabetes Mellitus Clinical Trial
A Study to Assess Cardiovascular Outcomes Following Treatment With MK-3102 in Participants With Type 2 Diabetes Mellitus (MK-3102-018)
Status: Enrolling,
Phase
III
Updated: 8/28/2014
Click here to add this to my saved trials
Type 2 Diabetes Mellitus Clinical Trial
A Study to Assess Cardiovascular Outcomes Following Treatment With MK-3102 in Participants With Type 2 Diabetes Mellitus (MK-3102-018)
Status: Enrolling,
Phase
III
Updated: 8/28/2014
Click here to add this to my saved trials
Type 2 Diabetes Mellitus Clinical Trial
A Study to Assess Cardiovascular Outcomes Following Treatment With MK-3102 in Participants With Type 2 Diabetes Mellitus (MK-3102-018)
Status: Enrolling,
Phase
III
Updated: 8/28/2014
Click here to add this to my saved trials
Type 2 Diabetes Mellitus Clinical Trial
A Study to Assess Cardiovascular Outcomes Following Treatment With MK-3102 in Participants With Type 2 Diabetes Mellitus (MK-3102-018)
Status: Enrolling,
Phase
III
Updated: 8/28/2014
Click here to add this to my saved trials
Type 2 Diabetes Mellitus Clinical Trial
A Study to Assess Cardiovascular Outcomes Following Treatment With MK-3102 in Participants With Type 2 Diabetes Mellitus (MK-3102-018)
Status: Enrolling,
Phase
III
Updated: 8/28/2014
Click here to add this to my saved trials
Type 2 Diabetes Mellitus Clinical Trial
A Study to Assess Cardiovascular Outcomes Following Treatment With MK-3102 in Participants With Type 2 Diabetes Mellitus (MK-3102-018)
Status: Enrolling,
Phase
III
Updated: 8/28/2014
Click here to add this to my saved trials
Type 2 Diabetes Mellitus Clinical Trial
A Study to Assess Cardiovascular Outcomes Following Treatment With MK-3102 in Participants With Type 2 Diabetes Mellitus (MK-3102-018)
Status: Enrolling,
Phase
III
Updated: 8/28/2014
Click here to add this to my saved trials
Type 2 Diabetes Mellitus Clinical Trial
A Study to Assess Cardiovascular Outcomes Following Treatment With MK-3102 in Participants With Type 2 Diabetes Mellitus (MK-3102-018)
Status: Enrolling,
Phase
III
Updated: 8/28/2014
Click here to add this to my saved trials
Type 2 Diabetes Mellitus Clinical Trial
A Study to Assess Cardiovascular Outcomes Following Treatment With MK-3102 in Participants With Type 2 Diabetes Mellitus (MK-3102-018)
Status: Enrolling,
Phase
III
Updated: 8/28/2014
Click here to add this to my saved trials
Type 2 Diabetes Mellitus Clinical Trial
A Study to Assess Cardiovascular Outcomes Following Treatment With MK-3102 in Participants With Type 2 Diabetes Mellitus (MK-3102-018)
Status: Enrolling,
Phase
III
Updated: 8/28/2014
Click here to add this to my saved trials
Type 2 Diabetes Mellitus Clinical Trial
A Study to Assess Cardiovascular Outcomes Following Treatment With MK-3102 in Participants With Type 2 Diabetes Mellitus (MK-3102-018)
Status: Enrolling,
Phase
III
Updated: 8/28/2014
Click here to add this to my saved trials
Type 2 Diabetes Mellitus Clinical Trial
A Study to Assess Cardiovascular Outcomes Following Treatment With MK-3102 in Participants With Type 2 Diabetes Mellitus (MK-3102-018)
Status: Enrolling,
Phase
III
Updated: 8/28/2014
Click here to add this to my saved trials
Type 2 Diabetes Mellitus Clinical Trial
A Study to Assess Cardiovascular Outcomes Following Treatment With MK-3102 in Participants With Type 2 Diabetes Mellitus (MK-3102-018)
Status: Enrolling,
Phase
III
Updated: 8/28/2014
Click here to add this to my saved trials
Type 2 Diabetes Mellitus Clinical Trial
A Study to Assess Cardiovascular Outcomes Following Treatment With MK-3102 in Participants With Type 2 Diabetes Mellitus (MK-3102-018)
Status: Enrolling,
Phase
III
Updated: 8/28/2014
Click here to add this to my saved trials
Type 2 Diabetes Mellitus Clinical Trial
A Study to Assess Cardiovascular Outcomes Following Treatment With MK-3102 in Participants With Type 2 Diabetes Mellitus (MK-3102-018)
Status: Enrolling,
Phase
III
Updated: 8/28/2014
Click here to add this to my saved trials
Type 2 Diabetes Mellitus Clinical Trial
A Study to Assess Cardiovascular Outcomes Following Treatment With MK-3102 in Participants With Type 2 Diabetes Mellitus (MK-3102-018)
Status: Enrolling,
Phase
III
Updated: 8/28/2014
Click here to add this to my saved trials
Type 2 Diabetes Mellitus Clinical Trial
A Study to Assess Cardiovascular Outcomes Following Treatment With MK-3102 in Participants With Type 2 Diabetes Mellitus (MK-3102-018)
Status: Enrolling,
Phase
III
Updated: 8/28/2014
Click here to add this to my saved trials
Type 2 Diabetes Mellitus Clinical Trial
A Study to Assess Cardiovascular Outcomes Following Treatment With MK-3102 in Participants With Type 2 Diabetes Mellitus (MK-3102-018)
Status: Enrolling,
Phase
III
Updated: 8/28/2014
Click here to add this to my saved trials
Type 2 Diabetes Mellitus Clinical Trial
A Study to Assess Cardiovascular Outcomes Following Treatment With MK-3102 in Participants With Type 2 Diabetes Mellitus (MK-3102-018)
Status: Enrolling,
Phase
III
Updated: 8/28/2014
Click here to add this to my saved trials
Type 2 Diabetes Mellitus Clinical Trial
A Study to Assess Cardiovascular Outcomes Following Treatment With MK-3102 in Participants With Type 2 Diabetes Mellitus (MK-3102-018)
Status: Enrolling,
Phase
III
Updated: 8/28/2014
Click here to add this to my saved trials
Oncology Clinical Trial
Whole Brain Radiotherapy (WBRT) With Sorafenib for Breast Cancer Brain Metastases (BCBM)
Status: Enrolling,
Phase
I
Updated: 12/31/1969
Click here to add this to my saved trials
Metastatic Melanoma Clinical Trial
Whole Brain Radiotherapy Following Local Treatment of Intracranial Metastases of Melanoma
Status: Enrolling,
Phase
III
Updated: 1/6/2016
Click here to add this to my saved trials
Plaque Psoriasis Clinical Trial
A Study to Evaluate the Efficacy and Safety of Subcutaneous MK-3222, Followed by an Optional Long-Term Safety Extension Study, in Participants With Moderate-to-Severe Chronic Plaque Psoriasis (MK-3222-010)
Status: Enrolling,
Phase
III
Updated: 2/28/2014
Click here to add this to my saved trials
Plaque Psoriasis Clinical Trial
A Study to Evaluate the Efficacy and Safety of Subcutaneous MK-3222, Followed by an Optional Long-Term Safety Extension Study, in Participants With Moderate-to-Severe Chronic Plaque Psoriasis (MK-3222-010)
Status: Enrolling,
Phase
III
Updated: 2/28/2014
Click here to add this to my saved trials
Plaque Psoriasis Clinical Trial
A Study to Evaluate the Efficacy and Safety of Subcutaneous MK-3222, Followed by an Optional Long-Term Safety Extension Study, in Participants With Moderate-to-Severe Chronic Plaque Psoriasis (MK-3222-010)
Status: Enrolling,
Phase
III
Updated: 2/28/2014
Click here to add this to my saved trials
Plaque Psoriasis Clinical Trial
A Study to Evaluate the Efficacy and Safety of Subcutaneous MK-3222, Followed by an Optional Long-Term Safety Extension Study, in Participants With Moderate-to-Severe Chronic Plaque Psoriasis (MK-3222-010)
Status: Enrolling,
Phase
III
Updated: 2/28/2014
Click here to add this to my saved trials
Plaque Psoriasis Clinical Trial
A Study to Evaluate the Efficacy and Safety of Subcutaneous MK-3222, Followed by an Optional Long-Term Safety Extension Study, in Participants With Moderate-to-Severe Chronic Plaque Psoriasis (MK-3222-010)
Status: Enrolling,
Phase
III
Updated: 2/28/2014
Click here to add this to my saved trials
Plaque Psoriasis Clinical Trial
A Study to Evaluate the Efficacy and Safety of Subcutaneous MK-3222, Followed by an Optional Long-Term Safety Extension Study, in Participants With Moderate-to-Severe Chronic Plaque Psoriasis (MK-3222-010)
Status: Enrolling,
Phase
III
Updated: 2/28/2014
Click here to add this to my saved trials
Endocrinology, Psychiatry / Psychology, Pulmonary / Respiratory Diseases Clinical Trial
Diabetes-Obstructive Sleep Apnea Treatment Trial
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Peripheral Arterial Disease Clinical Trial
Multi-Center Registry for Peripheral Arterial Disease Interventions and Outcomes
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Hematology Clinical Trial
Sickle Cell Anemia - A Comparative Study Between Three Ethnical Communities, a Multicenter Study
Status: Enrolling
Updated: 8/8/2017
Click here to add this to my saved trials
Spinal Cord Injury Clinical Trial
Improving Motor Function After Spinal Cord Injury
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Cystic Fibrosis Clinical Trial
Prevalence of Antibodies to Selected Porcine Viruses in Patients With Cystic Fibrosis Receiving Porcine-derived Pancreatic Enzyme Replacement Therapy
Status: Enrolling
Updated: 3/1/2016
Click here to add this to my saved trials
Cystic Fibrosis Clinical Trial
Prevalence of Antibodies to Selected Porcine Viruses in Patients With Cystic Fibrosis Receiving Porcine-derived Pancreatic Enzyme Replacement Therapy
Status: Enrolling
Updated: 3/1/2016
Click here to add this to my saved trials
Cystic Fibrosis Clinical Trial
Prevalence of Antibodies to Selected Porcine Viruses in Patients With Cystic Fibrosis Receiving Porcine-derived Pancreatic Enzyme Replacement Therapy
Status: Enrolling
Updated: 3/1/2016
Click here to add this to my saved trials
Cystic Fibrosis Clinical Trial
Prevalence of Antibodies to Selected Porcine Viruses in Patients With Cystic Fibrosis Receiving Porcine-derived Pancreatic Enzyme Replacement Therapy
Status: Enrolling
Updated: 3/1/2016
Click here to add this to my saved trials
Cystic Fibrosis Clinical Trial
Prevalence of Antibodies to Selected Porcine Viruses in Patients With Cystic Fibrosis Receiving Porcine-derived Pancreatic Enzyme Replacement Therapy
Status: Enrolling
Updated: 3/1/2016
Click here to add this to my saved trials
Cystic Fibrosis Clinical Trial
Prevalence of Antibodies to Selected Porcine Viruses in Patients With Cystic Fibrosis Receiving Porcine-derived Pancreatic Enzyme Replacement Therapy
Status: Enrolling
Updated: 3/1/2016
Click here to add this to my saved trials
Cystic Fibrosis Clinical Trial
Prevalence of Antibodies to Selected Porcine Viruses in Patients With Cystic Fibrosis Receiving Porcine-derived Pancreatic Enzyme Replacement Therapy
Status: Enrolling
Updated: 3/1/2016
Click here to add this to my saved trials
Cystic Fibrosis Clinical Trial
Prevalence of Antibodies to Selected Porcine Viruses in Patients With Cystic Fibrosis Receiving Porcine-derived Pancreatic Enzyme Replacement Therapy
Status: Enrolling
Updated: 3/1/2016
Click here to add this to my saved trials
Cystic Fibrosis Clinical Trial
Prevalence of Antibodies to Selected Porcine Viruses in Patients With Cystic Fibrosis Receiving Porcine-derived Pancreatic Enzyme Replacement Therapy
Status: Enrolling
Updated: 3/1/2016
Click here to add this to my saved trials
Cystic Fibrosis Clinical Trial
Prevalence of Antibodies to Selected Porcine Viruses in Patients With Cystic Fibrosis Receiving Porcine-derived Pancreatic Enzyme Replacement Therapy
Status: Enrolling
Updated: 3/1/2016
Click here to add this to my saved trials
Cystic Fibrosis Clinical Trial
Prevalence of Antibodies to Selected Porcine Viruses in Patients With Cystic Fibrosis Receiving Porcine-derived Pancreatic Enzyme Replacement Therapy
Status: Enrolling
Updated: 3/1/2016
Click here to add this to my saved trials
Chronic Lymphocytic Leukemia Clinical Trial
An Expanded Access, Open-Label Study of Obinutuzumab (GA101) Plus Chlorambucil in Patients With Previously Untreated Chronic Lymphocytic Leukemia
Status: Enrolling,
Phase
IV
Updated: 11/2/2015
Click here to add this to my saved trials
Chronic Lymphocytic Leukemia Clinical Trial
An Expanded Access, Open-Label Study of Obinutuzumab (GA101) Plus Chlorambucil in Patients With Previously Untreated Chronic Lymphocytic Leukemia
Status: Enrolling,
Phase
IV
Updated: 11/2/2015
Click here to add this to my saved trials
Chronic Lymphocytic Leukemia Clinical Trial
An Expanded Access, Open-Label Study of Obinutuzumab (GA101) Plus Chlorambucil in Patients With Previously Untreated Chronic Lymphocytic Leukemia
Status: Enrolling,
Phase
IV
Updated: 11/2/2015
Click here to add this to my saved trials
Chronic Lymphocytic Leukemia Clinical Trial
An Expanded Access, Open-Label Study of Obinutuzumab (GA101) Plus Chlorambucil in Patients With Previously Untreated Chronic Lymphocytic Leukemia
Status: Enrolling,
Phase
IV
Updated: 11/2/2015
Click here to add this to my saved trials
Chronic Lymphocytic Leukemia Clinical Trial
An Expanded Access, Open-Label Study of Obinutuzumab (GA101) Plus Chlorambucil in Patients With Previously Untreated Chronic Lymphocytic Leukemia
Status: Enrolling,
Phase
IV
Updated: 11/2/2015
Click here to add this to my saved trials
Non Small Cell Lung Cancer (NSCLC) Clinical Trial
Study of Two Doses of MK-3475 (Pembrolizumab) Versus Docetaxel in Previously-Treated Participants With Non-Small Cell Lung Cancer (MK-3475-010/KEYNOTE-010)
Status: Enrolling,
Phase
II, III
Updated: 1/14/2015
Click here to add this to my saved trials
Non Small Cell Lung Cancer (NSCLC) Clinical Trial
Study of Two Doses of MK-3475 (Pembrolizumab) Versus Docetaxel in Previously-Treated Participants With Non-Small Cell Lung Cancer (MK-3475-010/KEYNOTE-010)
Status: Enrolling,
Phase
II, III
Updated: 1/14/2015
Click here to add this to my saved trials
Non Small Cell Lung Cancer (NSCLC) Clinical Trial
Study of Two Doses of MK-3475 (Pembrolizumab) Versus Docetaxel in Previously-Treated Participants With Non-Small Cell Lung Cancer (MK-3475-010/KEYNOTE-010)
Status: Enrolling,
Phase
II, III
Updated: 1/14/2015
Click here to add this to my saved trials
Non Small Cell Lung Cancer (NSCLC) Clinical Trial
Study of Two Doses of MK-3475 (Pembrolizumab) Versus Docetaxel in Previously-Treated Participants With Non-Small Cell Lung Cancer (MK-3475-010/KEYNOTE-010)
Status: Enrolling,
Phase
II, III
Updated: 1/14/2015
Click here to add this to my saved trials
Non Small Cell Lung Cancer (NSCLC) Clinical Trial
Study of Two Doses of MK-3475 (Pembrolizumab) Versus Docetaxel in Previously-Treated Participants With Non-Small Cell Lung Cancer (MK-3475-010/KEYNOTE-010)
Status: Enrolling,
Phase
II, III
Updated: 1/14/2015
Click here to add this to my saved trials
Non Small Cell Lung Cancer (NSCLC) Clinical Trial
Study of Two Doses of MK-3475 (Pembrolizumab) Versus Docetaxel in Previously-Treated Participants With Non-Small Cell Lung Cancer (MK-3475-010/KEYNOTE-010)
Status: Enrolling,
Phase
II, III
Updated: 1/14/2015
Click here to add this to my saved trials
Non Small Cell Lung Cancer (NSCLC) Clinical Trial
Study of Two Doses of MK-3475 (Pembrolizumab) Versus Docetaxel in Previously-Treated Participants With Non-Small Cell Lung Cancer (MK-3475-010/KEYNOTE-010)
Status: Enrolling,
Phase
II, III
Updated: 1/14/2015
Click here to add this to my saved trials
Non Small Cell Lung Cancer (NSCLC) Clinical Trial
Study of Two Doses of MK-3475 (Pembrolizumab) Versus Docetaxel in Previously-Treated Participants With Non-Small Cell Lung Cancer (MK-3475-010/KEYNOTE-010)
Status: Enrolling,
Phase
II, III
Updated: 1/14/2015
Click here to add this to my saved trials
Non Small Cell Lung Cancer (NSCLC) Clinical Trial
Study of Two Doses of MK-3475 (Pembrolizumab) Versus Docetaxel in Previously-Treated Participants With Non-Small Cell Lung Cancer (MK-3475-010/KEYNOTE-010)
Status: Enrolling,
Phase
II, III
Updated: 1/14/2015
Click here to add this to my saved trials
Non Small Cell Lung Cancer (NSCLC) Clinical Trial
Study of Two Doses of MK-3475 (Pembrolizumab) Versus Docetaxel in Previously-Treated Participants With Non-Small Cell Lung Cancer (MK-3475-010/KEYNOTE-010)
Status: Enrolling,
Phase
II, III
Updated: 1/14/2015
Click here to add this to my saved trials
Chronic Idiopathic Constipation Clinical Trial
Open-label Extension (OLE) Study of Plecanatide for Chronic Idiopathic Constipation (CIC)
Status: Enrolling,
Phase
III
Updated: 12/10/2015
Click here to add this to my saved trials
Neoplasm Clinical Trial
A Study Of PF-05212384 In Combination With Other Anti-Tumor Agents and in Combination With Cisplatin in Patients With Triple Negative Breast Cancer in an Expansion Arm (TNBC)
Status: Enrolling,
Phase
I
Updated: 12/31/1969
Click here to add this to my saved trials
Acute Hematogenous Osteomyelitis Clinical Trial
Safety and Efficacy Study of Daptomycin Compared to Active Comparator in Pediatric Participants With Acute Hematogenous Osteomyelitis (AHO) (MK-3009-006)
Status: Enrolling,
Phase
III
Updated: 6/15/2016
Click here to add this to my saved trials
Acute Hematogenous Osteomyelitis Clinical Trial
Safety and Efficacy Study of Daptomycin Compared to Active Comparator in Pediatric Participants With Acute Hematogenous Osteomyelitis (AHO) (MK-3009-006)
Status: Enrolling,
Phase
III
Updated: 6/15/2016
Click here to add this to my saved trials
Acute Hematogenous Osteomyelitis Clinical Trial
Safety and Efficacy Study of Daptomycin Compared to Active Comparator in Pediatric Participants With Acute Hematogenous Osteomyelitis (AHO) (MK-3009-006)
Status: Enrolling,
Phase
III
Updated: 6/15/2016
Click here to add this to my saved trials
Oncology Clinical Trial
Adavosertib and Local Radiation Therapy in Treating Children With Newly Diagnosed Diffuse Intrinsic Pontine Gliomas
Status: Enrolling,
Phase
I
Updated: 12/31/1969
Click here to add this to my saved trials
Chronic Hypoparathyroidism Clinical Trial
A Registry for Patients With Chronic Hypoparathyroidism
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Adverse Effects in the Therapeutic Use of Plasma Substitutes Clinical Trial
Octaplas Pediatric Plasma Exchange Trial
Status: Enrolling,
Phase
IV
Updated: 12/31/1969
Click here to add this to my saved trials
Advanced Solid Tumors Clinical Trial
A Study of ABT-165 in Subjects With Solid Tumors
Status: Enrolling,
Phase
I
Updated: 12/31/1969
Click here to add this to my saved trials
Non-Small Cell Lung Cancer (NSCLC) Clinical Trial
Expanded Treatment Protocol With LDK378 in ALK(+) NSCLC
Status: Enrolling
Updated: 2/2/2018
Click here to add this to my saved trials
Safety and Tolerability Clinical Trial
Study Comparing the Pharmacokinetics, Pharmacodynamics, and Safety of K-312 in Healthy Adult Volunteers
Status: Enrolling
Updated: 9/25/2013
Click here to add this to my saved trials
Cancer Clinical Trial
A Dose Escalation Study to Investigate the Safety, Pharmacokinetics (PK), Pharmacodynamics (PD) and Clinical Activity of GSK525762 in Subjects With Relapsed, Refractory Hematologic Malignancies
Status: Enrolling,
Phase
I
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Neratinib HER Mutation Basket Study (SUMMIT)
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Neratinib HER Mutation Basket Study (SUMMIT)
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
AZD6738 First Time in Patient Multiple Ascending Dose Study
Status: Enrolling,
Phase
I
Updated: 4/3/2014
Click here to add this to my saved trials
Neoplasms by Site Clinical Trial
An Investigational Immuno-therapy Study to Assess the Safety, Tolerability and Effectiveness of Anti-LAG-3 With and Without Anti-PD-1 in the Treatment of Solid Tumors
Status: Enrolling,
Phase
I, II
Updated: 12/31/1969
Click here to add this to my saved trials
Neoplasms by Site Clinical Trial
An Investigational Immuno-therapy Study to Assess the Safety, Tolerability and Effectiveness of Anti-LAG-3 With and Without Anti-PD-1 in the Treatment of Solid Tumors
Status: Enrolling,
Phase
I, II
Updated: 12/31/1969
Click here to add this to my saved trials
Prostate Cancer Clinical Trial
Prostate Metabolomic Study
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Endocrinology, Neurology Clinical Trial
Vitamin K and Glucose Metabolism in Children at Risk for Diabetes (Vita-K 'n' Kids Study)
Status: Enrolling,
Phase
I, II
Updated: 12/31/1969
Click here to add this to my saved trials
Fungal Infections Clinical Trial
A Study of the Safety and Efficacy of Posaconazole Versus Voriconazole for the Treatment of Invasive Aspergillosis (MK-5592-069)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
We've found
184,457
clinical trials
Alzheimer's Disease Clinical Trial
Updated: 10/22/2015
An Efficacy and Safety Trial of Verubecestat (MK-8931) in Mild to Moderate Alzheimer's Disease (P07738)
Status: Enrolling,
Phase
II, III
Updated: 10/22/2015
Click here to add this to my saved trials
Alzheimer's Disease Clinical Trial
Updated: 10/22/2015
An Efficacy and Safety Trial of Verubecestat (MK-8931) in Mild to Moderate Alzheimer's Disease (P07738)
Status: Enrolling,
Phase
II, III
Updated: 10/22/2015
Click here to add this to my saved trials
Alzheimer's Disease Clinical Trial
Updated: 10/22/2015
An Efficacy and Safety Trial of Verubecestat (MK-8931) in Mild to Moderate Alzheimer's Disease (P07738)
Status: Enrolling,
Phase
II, III
Updated: 10/22/2015
Click here to add this to my saved trials
Alzheimer's Disease Clinical Trial
Updated: 10/22/2015
An Efficacy and Safety Trial of Verubecestat (MK-8931) in Mild to Moderate Alzheimer's Disease (P07738)
Status: Enrolling,
Phase
II, III
Updated: 10/22/2015
Click here to add this to my saved trials
Alzheimer's Disease Clinical Trial
Updated: 10/22/2015
An Efficacy and Safety Trial of Verubecestat (MK-8931) in Mild to Moderate Alzheimer's Disease (P07738)
Status: Enrolling,
Phase
II, III
Updated: 10/22/2015
Click here to add this to my saved trials
Type 2 Diabetes Mellitus Clinical Trial
Updated: 12/31/1969
A Study of the Safety and Efficacy of MK-0431A XR in Pediatric Participants With Type 2 Diabetes Mellitus (MK-0431A-289)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Type 2 Diabetes Mellitus Clinical Trial
Updated: 12/31/1969
A Study of the Safety and Efficacy of MK-0431A XR in Pediatric Participants With Type 2 Diabetes Mellitus (MK-0431A-289)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Neurology, Psychiatry / Psychology Clinical Trial
Updated: 12/31/1969
A Study of Brain Aging in Vietnam War Veterans
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Rheumatoid Arthritis (RA) Clinical Trial
Updated: 7/26/2013
Safety and Efficacy of MK-8457 and Methotrexate (MTX) in Patients With Active Rheumatoid Arthritis Despite MTX Therapy (MK-8457-008 AM6)
Status: Enrolling
Updated: 7/26/2013
Click here to add this to my saved trials
Non-Small Cell Lung Cancer Clinical Trial
Updated: 9/1/2015
A Multinational, Randomized, Open-Label Study of Custirsen In Patients With Advanced or Metastatic (Stage IV) Non-Small Cell Lung Cancer
Status: Enrolling,
Phase
III
Updated: 9/1/2015
Click here to add this to my saved trials
Relapsed or Refractory Systemic Light Chain Amyloidosis Clinical Trial
Updated: 12/31/1969
Study of Dexamethasone Plus IXAZOMIB (MLN9708) or Physicians Choice of Treatment in Relapsed or Refractory Systemic Light Chain (AL) Amyloidosis
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Medullary Thyroid Cancer Clinical Trial
Updated: 11/6/2012
Expanded Access of Cabozantinib in Medullary Thyroid Cancer
Status: Enrolling
Updated: 11/6/2012
Click here to add this to my saved trials
Pediatric Patients Treated With Proton Beam Radiation Therapy Clinical Trial
Updated: 12/31/1969
PPCR: Registry for Pedi Patients Treated With Proton RT
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Pediatric Patients Treated With Proton Beam Radiation Therapy Clinical Trial
Updated: 12/31/1969
PPCR: Registry for Pedi Patients Treated With Proton RT
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Hepatitis C Clinical Trial
Updated: 8/7/2014
An Open-Label Study of the Effect of Telaprevir in Combination With Peginterferon Alfa-2b and Ribavirin in Pediatric Subjects Infected With Hepatitis C Virus
Status: Enrolling,
Phase
I, II
Updated: 8/7/2014
Click here to add this to my saved trials
Hepatitis C Clinical Trial
Updated: 8/7/2014
An Open-Label Study of the Effect of Telaprevir in Combination With Peginterferon Alfa-2b and Ribavirin in Pediatric Subjects Infected With Hepatitis C Virus
Status: Enrolling,
Phase
I, II
Updated: 8/7/2014
Click here to add this to my saved trials
Type 2 Diabetes Mellitus Clinical Trial
Updated: 8/28/2014
A Study to Assess Cardiovascular Outcomes Following Treatment With MK-3102 in Participants With Type 2 Diabetes Mellitus (MK-3102-018)
Status: Enrolling,
Phase
III
Updated: 8/28/2014
Click here to add this to my saved trials
Type 2 Diabetes Mellitus Clinical Trial
Updated: 8/28/2014
A Study to Assess Cardiovascular Outcomes Following Treatment With MK-3102 in Participants With Type 2 Diabetes Mellitus (MK-3102-018)
Status: Enrolling,
Phase
III
Updated: 8/28/2014
Click here to add this to my saved trials
Type 2 Diabetes Mellitus Clinical Trial
Updated: 8/28/2014
A Study to Assess Cardiovascular Outcomes Following Treatment With MK-3102 in Participants With Type 2 Diabetes Mellitus (MK-3102-018)
Status: Enrolling,
Phase
III
Updated: 8/28/2014
Click here to add this to my saved trials
Type 2 Diabetes Mellitus Clinical Trial
Updated: 8/28/2014
A Study to Assess Cardiovascular Outcomes Following Treatment With MK-3102 in Participants With Type 2 Diabetes Mellitus (MK-3102-018)
Status: Enrolling,
Phase
III
Updated: 8/28/2014
Click here to add this to my saved trials
Type 2 Diabetes Mellitus Clinical Trial
Updated: 8/28/2014
A Study to Assess Cardiovascular Outcomes Following Treatment With MK-3102 in Participants With Type 2 Diabetes Mellitus (MK-3102-018)
Status: Enrolling,
Phase
III
Updated: 8/28/2014
Click here to add this to my saved trials
Type 2 Diabetes Mellitus Clinical Trial
Updated: 8/28/2014
A Study to Assess Cardiovascular Outcomes Following Treatment With MK-3102 in Participants With Type 2 Diabetes Mellitus (MK-3102-018)
Status: Enrolling,
Phase
III
Updated: 8/28/2014
Click here to add this to my saved trials
Type 2 Diabetes Mellitus Clinical Trial
Updated: 8/28/2014
A Study to Assess Cardiovascular Outcomes Following Treatment With MK-3102 in Participants With Type 2 Diabetes Mellitus (MK-3102-018)
Status: Enrolling,
Phase
III
Updated: 8/28/2014
Click here to add this to my saved trials
Type 2 Diabetes Mellitus Clinical Trial
Updated: 8/28/2014
A Study to Assess Cardiovascular Outcomes Following Treatment With MK-3102 in Participants With Type 2 Diabetes Mellitus (MK-3102-018)
Status: Enrolling,
Phase
III
Updated: 8/28/2014
Click here to add this to my saved trials
Type 2 Diabetes Mellitus Clinical Trial
Updated: 8/28/2014
A Study to Assess Cardiovascular Outcomes Following Treatment With MK-3102 in Participants With Type 2 Diabetes Mellitus (MK-3102-018)
Status: Enrolling,
Phase
III
Updated: 8/28/2014
Click here to add this to my saved trials
Type 2 Diabetes Mellitus Clinical Trial
Updated: 8/28/2014
A Study to Assess Cardiovascular Outcomes Following Treatment With MK-3102 in Participants With Type 2 Diabetes Mellitus (MK-3102-018)
Status: Enrolling,
Phase
III
Updated: 8/28/2014
Click here to add this to my saved trials
Type 2 Diabetes Mellitus Clinical Trial
Updated: 8/28/2014
A Study to Assess Cardiovascular Outcomes Following Treatment With MK-3102 in Participants With Type 2 Diabetes Mellitus (MK-3102-018)
Status: Enrolling,
Phase
III
Updated: 8/28/2014
Click here to add this to my saved trials
Type 2 Diabetes Mellitus Clinical Trial
Updated: 8/28/2014
A Study to Assess Cardiovascular Outcomes Following Treatment With MK-3102 in Participants With Type 2 Diabetes Mellitus (MK-3102-018)
Status: Enrolling,
Phase
III
Updated: 8/28/2014
Click here to add this to my saved trials
Type 2 Diabetes Mellitus Clinical Trial
Updated: 8/28/2014
A Study to Assess Cardiovascular Outcomes Following Treatment With MK-3102 in Participants With Type 2 Diabetes Mellitus (MK-3102-018)
Status: Enrolling,
Phase
III
Updated: 8/28/2014
Click here to add this to my saved trials
Type 2 Diabetes Mellitus Clinical Trial
Updated: 8/28/2014
A Study to Assess Cardiovascular Outcomes Following Treatment With MK-3102 in Participants With Type 2 Diabetes Mellitus (MK-3102-018)
Status: Enrolling,
Phase
III
Updated: 8/28/2014
Click here to add this to my saved trials
Type 2 Diabetes Mellitus Clinical Trial
Updated: 8/28/2014
A Study to Assess Cardiovascular Outcomes Following Treatment With MK-3102 in Participants With Type 2 Diabetes Mellitus (MK-3102-018)
Status: Enrolling,
Phase
III
Updated: 8/28/2014
Click here to add this to my saved trials
Type 2 Diabetes Mellitus Clinical Trial
Updated: 8/28/2014
A Study to Assess Cardiovascular Outcomes Following Treatment With MK-3102 in Participants With Type 2 Diabetes Mellitus (MK-3102-018)
Status: Enrolling,
Phase
III
Updated: 8/28/2014
Click here to add this to my saved trials
Type 2 Diabetes Mellitus Clinical Trial
Updated: 8/28/2014
A Study to Assess Cardiovascular Outcomes Following Treatment With MK-3102 in Participants With Type 2 Diabetes Mellitus (MK-3102-018)
Status: Enrolling,
Phase
III
Updated: 8/28/2014
Click here to add this to my saved trials
Type 2 Diabetes Mellitus Clinical Trial
Updated: 8/28/2014
A Study to Assess Cardiovascular Outcomes Following Treatment With MK-3102 in Participants With Type 2 Diabetes Mellitus (MK-3102-018)
Status: Enrolling,
Phase
III
Updated: 8/28/2014
Click here to add this to my saved trials
Type 2 Diabetes Mellitus Clinical Trial
Updated: 8/28/2014
A Study to Assess Cardiovascular Outcomes Following Treatment With MK-3102 in Participants With Type 2 Diabetes Mellitus (MK-3102-018)
Status: Enrolling,
Phase
III
Updated: 8/28/2014
Click here to add this to my saved trials
Type 2 Diabetes Mellitus Clinical Trial
Updated: 8/28/2014
A Study to Assess Cardiovascular Outcomes Following Treatment With MK-3102 in Participants With Type 2 Diabetes Mellitus (MK-3102-018)
Status: Enrolling,
Phase
III
Updated: 8/28/2014
Click here to add this to my saved trials
Type 2 Diabetes Mellitus Clinical Trial
Updated: 8/28/2014
A Study to Assess Cardiovascular Outcomes Following Treatment With MK-3102 in Participants With Type 2 Diabetes Mellitus (MK-3102-018)
Status: Enrolling,
Phase
III
Updated: 8/28/2014
Click here to add this to my saved trials
Type 2 Diabetes Mellitus Clinical Trial
Updated: 8/28/2014
A Study to Assess Cardiovascular Outcomes Following Treatment With MK-3102 in Participants With Type 2 Diabetes Mellitus (MK-3102-018)
Status: Enrolling,
Phase
III
Updated: 8/28/2014
Click here to add this to my saved trials
Type 2 Diabetes Mellitus Clinical Trial
Updated: 8/28/2014
A Study to Assess Cardiovascular Outcomes Following Treatment With MK-3102 in Participants With Type 2 Diabetes Mellitus (MK-3102-018)
Status: Enrolling,
Phase
III
Updated: 8/28/2014
Click here to add this to my saved trials
Type 2 Diabetes Mellitus Clinical Trial
Updated: 8/28/2014
A Study to Assess Cardiovascular Outcomes Following Treatment With MK-3102 in Participants With Type 2 Diabetes Mellitus (MK-3102-018)
Status: Enrolling,
Phase
III
Updated: 8/28/2014
Click here to add this to my saved trials
Type 2 Diabetes Mellitus Clinical Trial
Updated: 8/28/2014
A Study to Assess Cardiovascular Outcomes Following Treatment With MK-3102 in Participants With Type 2 Diabetes Mellitus (MK-3102-018)
Status: Enrolling,
Phase
III
Updated: 8/28/2014
Click here to add this to my saved trials
Type 2 Diabetes Mellitus Clinical Trial
Updated: 8/28/2014
A Study to Assess Cardiovascular Outcomes Following Treatment With MK-3102 in Participants With Type 2 Diabetes Mellitus (MK-3102-018)
Status: Enrolling,
Phase
III
Updated: 8/28/2014
Click here to add this to my saved trials
Oncology Clinical Trial
Updated: 12/31/1969
Whole Brain Radiotherapy (WBRT) With Sorafenib for Breast Cancer Brain Metastases (BCBM)
Status: Enrolling,
Phase
I
Updated: 12/31/1969
Click here to add this to my saved trials
Metastatic Melanoma Clinical Trial
Updated: 1/6/2016
Whole Brain Radiotherapy Following Local Treatment of Intracranial Metastases of Melanoma
Status: Enrolling,
Phase
III
Updated: 1/6/2016
Click here to add this to my saved trials
Plaque Psoriasis Clinical Trial
Updated: 2/28/2014
A Study to Evaluate the Efficacy and Safety of Subcutaneous MK-3222, Followed by an Optional Long-Term Safety Extension Study, in Participants With Moderate-to-Severe Chronic Plaque Psoriasis (MK-3222-010)
Status: Enrolling,
Phase
III
Updated: 2/28/2014
Click here to add this to my saved trials
Plaque Psoriasis Clinical Trial
Updated: 2/28/2014
A Study to Evaluate the Efficacy and Safety of Subcutaneous MK-3222, Followed by an Optional Long-Term Safety Extension Study, in Participants With Moderate-to-Severe Chronic Plaque Psoriasis (MK-3222-010)
Status: Enrolling,
Phase
III
Updated: 2/28/2014
Click here to add this to my saved trials
Plaque Psoriasis Clinical Trial
Updated: 2/28/2014
A Study to Evaluate the Efficacy and Safety of Subcutaneous MK-3222, Followed by an Optional Long-Term Safety Extension Study, in Participants With Moderate-to-Severe Chronic Plaque Psoriasis (MK-3222-010)
Status: Enrolling,
Phase
III
Updated: 2/28/2014
Click here to add this to my saved trials
Plaque Psoriasis Clinical Trial
Updated: 2/28/2014
A Study to Evaluate the Efficacy and Safety of Subcutaneous MK-3222, Followed by an Optional Long-Term Safety Extension Study, in Participants With Moderate-to-Severe Chronic Plaque Psoriasis (MK-3222-010)
Status: Enrolling,
Phase
III
Updated: 2/28/2014
Click here to add this to my saved trials
Plaque Psoriasis Clinical Trial
Updated: 2/28/2014
A Study to Evaluate the Efficacy and Safety of Subcutaneous MK-3222, Followed by an Optional Long-Term Safety Extension Study, in Participants With Moderate-to-Severe Chronic Plaque Psoriasis (MK-3222-010)
Status: Enrolling,
Phase
III
Updated: 2/28/2014
Click here to add this to my saved trials
Plaque Psoriasis Clinical Trial
Updated: 2/28/2014
A Study to Evaluate the Efficacy and Safety of Subcutaneous MK-3222, Followed by an Optional Long-Term Safety Extension Study, in Participants With Moderate-to-Severe Chronic Plaque Psoriasis (MK-3222-010)
Status: Enrolling,
Phase
III
Updated: 2/28/2014
Click here to add this to my saved trials
Endocrinology, Psychiatry / Psychology, Pulmonary / Respiratory Diseases Clinical Trial
Updated: 12/31/1969
Diabetes-Obstructive Sleep Apnea Treatment Trial
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Peripheral Arterial Disease Clinical Trial
Updated: 12/31/1969
Multi-Center Registry for Peripheral Arterial Disease Interventions and Outcomes
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Hematology Clinical Trial
Updated: 8/8/2017
Sickle Cell Anemia - A Comparative Study Between Three Ethnical Communities, a Multicenter Study
Status: Enrolling
Updated: 8/8/2017
Click here to add this to my saved trials
Spinal Cord Injury Clinical Trial
Updated: 12/31/1969
Improving Motor Function After Spinal Cord Injury
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Cystic Fibrosis Clinical Trial
Updated: 3/1/2016
Prevalence of Antibodies to Selected Porcine Viruses in Patients With Cystic Fibrosis Receiving Porcine-derived Pancreatic Enzyme Replacement Therapy
Status: Enrolling
Updated: 3/1/2016
Click here to add this to my saved trials
Cystic Fibrosis Clinical Trial
Updated: 3/1/2016
Prevalence of Antibodies to Selected Porcine Viruses in Patients With Cystic Fibrosis Receiving Porcine-derived Pancreatic Enzyme Replacement Therapy
Status: Enrolling
Updated: 3/1/2016
Click here to add this to my saved trials
Cystic Fibrosis Clinical Trial
Updated: 3/1/2016
Prevalence of Antibodies to Selected Porcine Viruses in Patients With Cystic Fibrosis Receiving Porcine-derived Pancreatic Enzyme Replacement Therapy
Status: Enrolling
Updated: 3/1/2016
Click here to add this to my saved trials
Cystic Fibrosis Clinical Trial
Updated: 3/1/2016
Prevalence of Antibodies to Selected Porcine Viruses in Patients With Cystic Fibrosis Receiving Porcine-derived Pancreatic Enzyme Replacement Therapy
Status: Enrolling
Updated: 3/1/2016
Click here to add this to my saved trials
Cystic Fibrosis Clinical Trial
Updated: 3/1/2016
Prevalence of Antibodies to Selected Porcine Viruses in Patients With Cystic Fibrosis Receiving Porcine-derived Pancreatic Enzyme Replacement Therapy
Status: Enrolling
Updated: 3/1/2016
Click here to add this to my saved trials
Cystic Fibrosis Clinical Trial
Updated: 3/1/2016
Prevalence of Antibodies to Selected Porcine Viruses in Patients With Cystic Fibrosis Receiving Porcine-derived Pancreatic Enzyme Replacement Therapy
Status: Enrolling
Updated: 3/1/2016
Click here to add this to my saved trials
Cystic Fibrosis Clinical Trial
Updated: 3/1/2016
Prevalence of Antibodies to Selected Porcine Viruses in Patients With Cystic Fibrosis Receiving Porcine-derived Pancreatic Enzyme Replacement Therapy
Status: Enrolling
Updated: 3/1/2016
Click here to add this to my saved trials
Cystic Fibrosis Clinical Trial
Updated: 3/1/2016
Prevalence of Antibodies to Selected Porcine Viruses in Patients With Cystic Fibrosis Receiving Porcine-derived Pancreatic Enzyme Replacement Therapy
Status: Enrolling
Updated: 3/1/2016
Click here to add this to my saved trials
Cystic Fibrosis Clinical Trial
Updated: 3/1/2016
Prevalence of Antibodies to Selected Porcine Viruses in Patients With Cystic Fibrosis Receiving Porcine-derived Pancreatic Enzyme Replacement Therapy
Status: Enrolling
Updated: 3/1/2016
Click here to add this to my saved trials
Cystic Fibrosis Clinical Trial
Updated: 3/1/2016
Prevalence of Antibodies to Selected Porcine Viruses in Patients With Cystic Fibrosis Receiving Porcine-derived Pancreatic Enzyme Replacement Therapy
Status: Enrolling
Updated: 3/1/2016
Click here to add this to my saved trials
Cystic Fibrosis Clinical Trial
Updated: 3/1/2016
Prevalence of Antibodies to Selected Porcine Viruses in Patients With Cystic Fibrosis Receiving Porcine-derived Pancreatic Enzyme Replacement Therapy
Status: Enrolling
Updated: 3/1/2016
Click here to add this to my saved trials
Chronic Lymphocytic Leukemia Clinical Trial
Updated: 11/2/2015
An Expanded Access, Open-Label Study of Obinutuzumab (GA101) Plus Chlorambucil in Patients With Previously Untreated Chronic Lymphocytic Leukemia
Status: Enrolling,
Phase
IV
Updated: 11/2/2015
Click here to add this to my saved trials
Chronic Lymphocytic Leukemia Clinical Trial
Updated: 11/2/2015
An Expanded Access, Open-Label Study of Obinutuzumab (GA101) Plus Chlorambucil in Patients With Previously Untreated Chronic Lymphocytic Leukemia
Status: Enrolling,
Phase
IV
Updated: 11/2/2015
Click here to add this to my saved trials
Chronic Lymphocytic Leukemia Clinical Trial
Updated: 11/2/2015
An Expanded Access, Open-Label Study of Obinutuzumab (GA101) Plus Chlorambucil in Patients With Previously Untreated Chronic Lymphocytic Leukemia
Status: Enrolling,
Phase
IV
Updated: 11/2/2015
Click here to add this to my saved trials
Chronic Lymphocytic Leukemia Clinical Trial
Updated: 11/2/2015
An Expanded Access, Open-Label Study of Obinutuzumab (GA101) Plus Chlorambucil in Patients With Previously Untreated Chronic Lymphocytic Leukemia
Status: Enrolling,
Phase
IV
Updated: 11/2/2015
Click here to add this to my saved trials
Chronic Lymphocytic Leukemia Clinical Trial
Updated: 11/2/2015
An Expanded Access, Open-Label Study of Obinutuzumab (GA101) Plus Chlorambucil in Patients With Previously Untreated Chronic Lymphocytic Leukemia
Status: Enrolling,
Phase
IV
Updated: 11/2/2015
Click here to add this to my saved trials
Non Small Cell Lung Cancer (NSCLC) Clinical Trial
Updated: 1/14/2015
Study of Two Doses of MK-3475 (Pembrolizumab) Versus Docetaxel in Previously-Treated Participants With Non-Small Cell Lung Cancer (MK-3475-010/KEYNOTE-010)
Status: Enrolling,
Phase
II, III
Updated: 1/14/2015
Click here to add this to my saved trials
Non Small Cell Lung Cancer (NSCLC) Clinical Trial
Updated: 1/14/2015
Study of Two Doses of MK-3475 (Pembrolizumab) Versus Docetaxel in Previously-Treated Participants With Non-Small Cell Lung Cancer (MK-3475-010/KEYNOTE-010)
Status: Enrolling,
Phase
II, III
Updated: 1/14/2015
Click here to add this to my saved trials
Non Small Cell Lung Cancer (NSCLC) Clinical Trial
Updated: 1/14/2015
Study of Two Doses of MK-3475 (Pembrolizumab) Versus Docetaxel in Previously-Treated Participants With Non-Small Cell Lung Cancer (MK-3475-010/KEYNOTE-010)
Status: Enrolling,
Phase
II, III
Updated: 1/14/2015
Click here to add this to my saved trials
Non Small Cell Lung Cancer (NSCLC) Clinical Trial
Updated: 1/14/2015
Study of Two Doses of MK-3475 (Pembrolizumab) Versus Docetaxel in Previously-Treated Participants With Non-Small Cell Lung Cancer (MK-3475-010/KEYNOTE-010)
Status: Enrolling,
Phase
II, III
Updated: 1/14/2015
Click here to add this to my saved trials
Non Small Cell Lung Cancer (NSCLC) Clinical Trial
Updated: 1/14/2015
Study of Two Doses of MK-3475 (Pembrolizumab) Versus Docetaxel in Previously-Treated Participants With Non-Small Cell Lung Cancer (MK-3475-010/KEYNOTE-010)
Status: Enrolling,
Phase
II, III
Updated: 1/14/2015
Click here to add this to my saved trials
Non Small Cell Lung Cancer (NSCLC) Clinical Trial
Updated: 1/14/2015
Study of Two Doses of MK-3475 (Pembrolizumab) Versus Docetaxel in Previously-Treated Participants With Non-Small Cell Lung Cancer (MK-3475-010/KEYNOTE-010)
Status: Enrolling,
Phase
II, III
Updated: 1/14/2015
Click here to add this to my saved trials
Non Small Cell Lung Cancer (NSCLC) Clinical Trial
Updated: 1/14/2015
Study of Two Doses of MK-3475 (Pembrolizumab) Versus Docetaxel in Previously-Treated Participants With Non-Small Cell Lung Cancer (MK-3475-010/KEYNOTE-010)
Status: Enrolling,
Phase
II, III
Updated: 1/14/2015
Click here to add this to my saved trials
Non Small Cell Lung Cancer (NSCLC) Clinical Trial
Updated: 1/14/2015
Study of Two Doses of MK-3475 (Pembrolizumab) Versus Docetaxel in Previously-Treated Participants With Non-Small Cell Lung Cancer (MK-3475-010/KEYNOTE-010)
Status: Enrolling,
Phase
II, III
Updated: 1/14/2015
Click here to add this to my saved trials
Non Small Cell Lung Cancer (NSCLC) Clinical Trial
Updated: 1/14/2015
Study of Two Doses of MK-3475 (Pembrolizumab) Versus Docetaxel in Previously-Treated Participants With Non-Small Cell Lung Cancer (MK-3475-010/KEYNOTE-010)
Status: Enrolling,
Phase
II, III
Updated: 1/14/2015
Click here to add this to my saved trials
Non Small Cell Lung Cancer (NSCLC) Clinical Trial
Updated: 1/14/2015
Study of Two Doses of MK-3475 (Pembrolizumab) Versus Docetaxel in Previously-Treated Participants With Non-Small Cell Lung Cancer (MK-3475-010/KEYNOTE-010)
Status: Enrolling,
Phase
II, III
Updated: 1/14/2015
Click here to add this to my saved trials
Chronic Idiopathic Constipation Clinical Trial
Updated: 12/10/2015
Open-label Extension (OLE) Study of Plecanatide for Chronic Idiopathic Constipation (CIC)
Status: Enrolling,
Phase
III
Updated: 12/10/2015
Click here to add this to my saved trials
Neoplasm Clinical Trial
Updated: 12/31/1969
A Study Of PF-05212384 In Combination With Other Anti-Tumor Agents and in Combination With Cisplatin in Patients With Triple Negative Breast Cancer in an Expansion Arm (TNBC)
Status: Enrolling,
Phase
I
Updated: 12/31/1969
Click here to add this to my saved trials
Acute Hematogenous Osteomyelitis Clinical Trial
Updated: 6/15/2016
Safety and Efficacy Study of Daptomycin Compared to Active Comparator in Pediatric Participants With Acute Hematogenous Osteomyelitis (AHO) (MK-3009-006)
Status: Enrolling,
Phase
III
Updated: 6/15/2016
Click here to add this to my saved trials
Acute Hematogenous Osteomyelitis Clinical Trial
Updated: 6/15/2016
Safety and Efficacy Study of Daptomycin Compared to Active Comparator in Pediatric Participants With Acute Hematogenous Osteomyelitis (AHO) (MK-3009-006)
Status: Enrolling,
Phase
III
Updated: 6/15/2016
Click here to add this to my saved trials
Acute Hematogenous Osteomyelitis Clinical Trial
Updated: 6/15/2016
Safety and Efficacy Study of Daptomycin Compared to Active Comparator in Pediatric Participants With Acute Hematogenous Osteomyelitis (AHO) (MK-3009-006)
Status: Enrolling,
Phase
III
Updated: 6/15/2016
Click here to add this to my saved trials
Oncology Clinical Trial
Updated: 12/31/1969
Adavosertib and Local Radiation Therapy in Treating Children With Newly Diagnosed Diffuse Intrinsic Pontine Gliomas
Status: Enrolling,
Phase
I
Updated: 12/31/1969
Click here to add this to my saved trials
Chronic Hypoparathyroidism Clinical Trial
Updated: 12/31/1969
A Registry for Patients With Chronic Hypoparathyroidism
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Adverse Effects in the Therapeutic Use of Plasma Substitutes Clinical Trial
Updated: 12/31/1969
Octaplas Pediatric Plasma Exchange Trial
Status: Enrolling,
Phase
IV
Updated: 12/31/1969
Click here to add this to my saved trials
Advanced Solid Tumors Clinical Trial
Updated: 12/31/1969
A Study of ABT-165 in Subjects With Solid Tumors
Status: Enrolling,
Phase
I
Updated: 12/31/1969
Click here to add this to my saved trials
Non-Small Cell Lung Cancer (NSCLC) Clinical Trial
Updated: 2/2/2018
Expanded Treatment Protocol With LDK378 in ALK(+) NSCLC
Status: Enrolling
Updated: 2/2/2018
Click here to add this to my saved trials
Safety and Tolerability Clinical Trial
Updated: 9/25/2013
Study Comparing the Pharmacokinetics, Pharmacodynamics, and Safety of K-312 in Healthy Adult Volunteers
Status: Enrolling
Updated: 9/25/2013
Click here to add this to my saved trials
Cancer Clinical Trial
Updated: 12/31/1969
A Dose Escalation Study to Investigate the Safety, Pharmacokinetics (PK), Pharmacodynamics (PD) and Clinical Activity of GSK525762 in Subjects With Relapsed, Refractory Hematologic Malignancies
Status: Enrolling,
Phase
I
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Updated: 12/31/1969
Neratinib HER Mutation Basket Study (SUMMIT)
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Updated: 12/31/1969
Neratinib HER Mutation Basket Study (SUMMIT)
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Updated: 4/3/2014
AZD6738 First Time in Patient Multiple Ascending Dose Study
Status: Enrolling,
Phase
I
Updated: 4/3/2014
Click here to add this to my saved trials
Neoplasms by Site Clinical Trial
Updated: 12/31/1969
An Investigational Immuno-therapy Study to Assess the Safety, Tolerability and Effectiveness of Anti-LAG-3 With and Without Anti-PD-1 in the Treatment of Solid Tumors
Status: Enrolling,
Phase
I, II
Updated: 12/31/1969
Click here to add this to my saved trials
Neoplasms by Site Clinical Trial
Updated: 12/31/1969
An Investigational Immuno-therapy Study to Assess the Safety, Tolerability and Effectiveness of Anti-LAG-3 With and Without Anti-PD-1 in the Treatment of Solid Tumors
Status: Enrolling,
Phase
I, II
Updated: 12/31/1969
Click here to add this to my saved trials
Prostate Cancer Clinical Trial
Updated: 12/31/1969
Prostate Metabolomic Study
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Endocrinology, Neurology Clinical Trial
Updated: 12/31/1969
Vitamin K and Glucose Metabolism in Children at Risk for Diabetes (Vita-K 'n' Kids Study)
Status: Enrolling,
Phase
I, II
Updated: 12/31/1969
Click here to add this to my saved trials
Fungal Infections Clinical Trial
Updated: 12/31/1969
A Study of the Safety and Efficacy of Posaconazole Versus Voriconazole for the Treatment of Invasive Aspergillosis (MK-5592-069)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials